Hinge Health (HNGE)
Combines motion tracking, wearable therapy, and clinicians for employer-sponsored musculoskeletal care.
Something off on this page? Send us feedback.
Delivers digital musculoskeletal care through AI-powered motion tracking, Enso electrical nerve stimulation, and clinician-supported programs. Primary clients are self-insured employers that make access available to eligible employees and adult dependents, combining software, wearable hardware, and care teams in one service.
Delivers digital musculoskeletal care for joint and muscle pain through an integrated platform serving primarily self-insured employers. Eligible employees and adult dependents receive programs that combine AI-powered motion tracking, Enso electrical nerve stimulation, and support from licensed physical therapists, physicians, and board-certified health coaches.
Care spans treatment and prevention rather than a narrow telehealth visit, joining software, wearable hardware, and clinical teams in one service. The founder-led company operates from San Francisco after moving there from London.
Access is tied to employers making the platform available as a workforce benefit. Delivery relies on proprietary technology, the Enso wearable, and licensed care staff working together.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 22, 2026 | Robert W. Baird | Target | Target: $65 | Target: $90 |
| Sep 8, 2026 | Stifel Nicolaus | Target | Target: $96 | Target: $115 |
| Aug 10, 2026 | Truist Financial | Target | Target: $85 | Target: $112 |
| Aug 5, 2026 | Evercore ISI | Reiterate | Rating: —Target: $45 | Target: $105 |
| Aug 5, 2026 | RBC Capital | Reiterate | Rating: —Target: $75 | Target: $110 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $389.4M · Total debt $5.9M · Total assets $827.4M · Shareholders' equity $344.3M
- Revenue
- $212.8M
- Operating income
- $40.4M
- Net income
- $43.7M
No dividends on record.
| Institutions | ≈ 71.87% | 55.61M shares | |
|---|---|---|---|
| 292 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 13.42% | 10.39M shares | |
| 3 holders · as of Aug 12, 2026 | |||
| Strategic holders | 20.56% | 15.91M shares | |
| 4 holders · as of Jul 9, 2026 | |||
| Adds to | 105.85% | ||
77.38M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 105.85%; nothing is left for Other.
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Daniel Antonio Perez1Insiderdirector, 10 percent owner, officer: CEO & Co-Founder | 13.41% | 9.99M B · 14.72M | filed Feb 13, 2026 |
Atomico Advisors IV, Ltd.2Strategic10 percent owner | 8.68% | 6.71M B | filed May 27, 2025 |
11.2 Capital I Partners, LLCStrategic10 percent owner | 4.79% | 3.70M B | filed May 27, 2025 |
BlackRock, Inc.Institution | 4.61% | 3.57M A | as of Jun 30, 2026 |
Bessemer Venture Partners X L.P.3Strategic10 percent owner | 4.37% | 3.38M A | filed Nov 20, 2025 |
- The filed share classes (A, B, COMMON) could not be matched to the company's, so no percentage.
- Reported at 2.88% on Jun 8, 2026, under the 5% line, so no further filing is required.
- Reported at 4.30% on Feb 17, 2026, under the 5% line, so no further filing is required.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 14, 2026 | Elliott Robinson | director | 0 | |
| Sep 14, 2026 | Gabriel M.I. Mecklenburg | director, other: Exec. Chairman & Co-Founder | −150,000 | $93.22 |
| Sep 11, 2026 | Gabriel M.I. Mecklenburg | director, other: Exec. Chairman & Co-Founder | −250,000 | $88.97 |
| Sep 10, 2026 | Daniel Antonio Perez | director, 10 percent owner, officer: CEO & Co-Founder | −250,000 | $89.45 |
| Sep 10, 2026 | James Budge | officer: Chief Financial Officer | −55,561 | $89.45 |
- Omada Health
Direct virtual MSK and employer-benefits platform rival
- DarioHealth
Digital MSK pain platform competing for employer and health-plan clients
- U.S. Physical Therapy
In-person physical therapy and workplace injury-prevention alternative
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Hinge Health | $92.92 | −1.62% | $7.31B | 73.4 | 35.3 | 10.1 | +53.0% |
| Omada Health | $21.07 | +2.24% | $1.23B | 327.1 | 70.9 | 4.0 | +43.1% |
| DarioHealth | $6.97 | −1.41% | $51.7M | 10.2 | — | 2.5 | −3.6% |
| U.S. Physical Therapy | $83.71 | +1.53% | $1.25B | 485.0 | 26.8 | 1.6 | +30.4% |
| Median | 327.1 | 48.8 | 2.5 | +30.4% |